0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Food & Water Human Health Effects Remediation Sign in to save

An Integrated Comprehensive Peptidomics and In Silico Analysis of Bioactive Peptide-Rich Milk Fermented by Three Autochthonous Cocci Strains

International Journal of Molecular Sciences 2024 8 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 55 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Martina Banić, Katarina Butorac, Nina Čuljak, Ana Butorac, Jasna Novak, Andreja Leboš Pavunc, Anamarija Rušanac, Ana Butorac, Anamarija Rušanac, Željka Stanečić, Željka Stanečić, Marija Lovrić, Jagoda Šušković, Blaženka Kos

Summary

Researchers used three bacterial strains isolated from artisanal dairy products to ferment milk and then analyzed the bioactive peptides produced using advanced peptidomics techniques. They identified numerous peptides with potential antioxidant, antimicrobial, and blood-pressure-lowering properties. The study suggests that fermented dairy products made with these specific starter cultures could serve as functional foods with health-supporting benefits.

Bioactive peptides (BPs) are molecules of paramount importance with great potential for the development of functional foods, nutraceuticals or therapeutics for the prevention or treatment of various diseases. A functional BP-rich dairy product was produced by lyophilisation of bovine milk fermented by the autochthonous strains <i>Lactococcus lactis</i> subsp. <i>lactis</i> ZGBP5-51, <i>Enterococcus faecium</i> ZGBP5-52 and <i>Enterococcus faecalis</i> ZGBP5-53 isolated from the same artisanal fresh cheese. The efficiency of the proteolytic system of the implemented strains in the production of BPs was confirmed by a combined high-throughput mass spectrometry (MS)-based peptidome profiling and an in silico approach. First, peptides released by microbial fermentation were identified via a non-targeted peptide analysis (NTA) comprising reversed-phase nano-liquid chromatography (RP nano-LC) coupled with matrix-assisted laser desorption/ionisation-time-of-flight/time-of-flight (MALDI-TOF/TOF) MS, and then quantified by targeted peptide analysis (TA) involving RP ultrahigh-performance LC (RP-UHPLC) coupled with triple-quadrupole MS (QQQ-MS). A combined database and literature search revealed that 10 of the 25 peptides identified in this work have bioactive properties described in the literature. Finally, by combining the output of MS-based peptidome profiling with in silico bioactivity prediction tools, three peptides (<sup>75</sup>QFLPYPYYAKPA<sup>86</sup>, <sup>40</sup>VAPFPEVFGK<sup>49</sup>, <sup>117</sup>ARHPHPHLSF<sup>126</sup>), whose bioactive properties have not been previously reported in the literature, were identified as potential BP candidates.

Sign in to start a discussion.

Share this paper